AAMDSIF sponsors live education events throughout the year. This includes satellite symposia at annual medical association meetings, as well as smaller live regional events where community-based health professionals can hear from leading experts. The International Bone Marrow Failure Disease Scientific Symposium is our biennial professional meeting held near Washington, DC.
Seventh International Bone Marrow Failure Scientific Symposium
**In light of the COVID-19 pandemic, AAMDSIF will be conducting this Biennial International Scientific Symposium virtually.
Collaborating to Transform Treatment and Improve Outcomes
July 15th, 16th & 17th | Virtual sessions, discussions and poster session
An Intensive Three-Day Virtual Conference Convening International Experts at the Forefront of Research and Treatment of Bone Marrow Failure Disease. This symposium will bring together physicians treating these diseases and laboratory researchers studying the immunology and cell biology of bone marrow failure disease to:
- Discuss current areas of controversy
- Share recent research results
- Propose specific recommendations for the highest priority directions for basic and clinical research needed to advance the field of research
Once thought of as distinct, aplastic anemia, myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH) are now believed to be linked by similar pathophysiologic pathways.
With exciting new developments in the treatment of these diseases and new insights into the molecular pathogenesis of the diseases, AAMDSIF is coordinating this symposium to explore opportunities for collaborative research.
The symposium program has been designed to address the most up-to-date issues in each topic area and to encourage participant interaction. Each session includes presentations by experts in the field followed by open discussion.
Poster session and networking opportunities are included in the program.
Symposium Information and Registration
Guidelines for Submission of Poster Abstracts:
-
All submissions must be in English. The first sentence must state the purposes or specific objectives of the study. Methods should describe the study design, subjects, and evaluative procedures. Clear documentation of statistical methodology should accompany the methods/results section. A summary of the results must be stated in the abstract to support the final conclusions. Please do not include statements about providing further data or conclusions at the time the abstract is posted.
-
Abstracts of posters are limited to 2500 words in length and must be presented on a single page.
-
Abstracts must present new data. The author must certify that no prior copyright or ownership applies to the abstract or poster.
-
Once an abstract is accepted, it may not be revised prior to the symposium. Updated material may be presented in the virtual poster session.
-
Instructions for submitting the virtual poster session content will be provide with the notification of acceptance.
-
The Virtual Poster Session will be accessible on the symposium virtual meeting portal beginning July 15th and for 30 days following the symposium.
-
At least one author of poster is expected to register for the symposium.
Great Debates and Updates in Hematological Malignancies
March 6-7, 2020 | Los Angeles, CA
July 17-18, 2020 | New York, NY (Previously May 1-2)
August 28-29, 2020 | Chicago, IL (Previously April 3-4)
In this 2-day, debate-style series, nationally recognized thought leaders take opposing sides on clinical—and sometimes controversial—topics currently disrupting the practice of hematology and oncology. Through comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.
Use code ENDORSER for $50 off registration
https://hematologicmalignancies.oncnet.com/